The 17th Annual Mild Cognitive Impairment (MCI) Symposium -- Miami Beach Fl, 19-20 Jan 2019

Diagnosis and Non-Pharmacolgical Treatment of Neurodegenerative and Vascular MCI --

January 19-20, 2019 Miami Beach, FL

Online PR News – 14-December-2018 – Miami Beach, FL – The Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center and 1Florida ADRC will present the 17th Annual MCI Symposium titled:

Diagnosis and Non-Pharmacolgical Treatment of Neurodegenerative and Vascular MCI
January 19-20, 2019 in Miami Beach, FL

The Symposium will include sessions on:

• Interaction of Vascular and Neurodegenerative Disease
• Multimodal Imaging in the Diagnosis of Incipient Neurodegenerative diseases
• Neurorehabilitation for MCI
• Acculturative Stress, Discrimination and Cognitive Performance in the Older Adults
• MCI: Early Diagnosis and the Impact of Stress, Culture and Memory Training.

This event will offer up to 12.75 CME and CE (APA) credits (included in the registration fee). Additional information is available at the website:
Early bird registration ends on December 20, 2018.

For sponsorship opportunities and any other questions, please contact the secretariat c/o World Events Forum, Inc.,, Tel: +1.224.938.9523,

The Wien Center for Alzheimer's Disease and Memory Disorders at Mount Sinai Medical Center Miami Beach, since its inception in 1986, has provided clinical care in the form of diagnosis, comprehensive neurological, psychiatric, social service and outreach services to patients and their caregivers in South Florida, the Caribbean and Central and South America. The center has been in the forefront of providing education about memory disorders to professionals and the community at large. The MCI Symposium is a vehicle for this learning process, not only for the center and for the residents of South Florida, but also for the many individuals who travel to Miami Beach to attend these events each year.

1Florida Alzheimer's Disease & Research Center, funded by the National Institute on Aging, creates the infrastructure that supports research and educational activities as well as clinical care for patients with AD and other dementias in Florida. Nearly one in eight of the 5.7 million Americans living with Alzheimer's Disease resides in Florida. The 1Florida ADRC coalesces research efforts of the Wien Memory Disorder Center at Mount Sinai Medical Center Miami and the University of Florida (UF) in Gainesville. These efforts capitalize on the clinic population in the Wien Center that is majority Hispanic, the expansive research capabilities at UF, and the infrastructure for translational research provided by the NIH funded UF Clinical and Translational Science Institute.


MCI (Mild Cognitive Impairment)
Vascular Dementia
Amyloid imaging
Neurodegenerative disorders


Nico Stanculescu